Owner Merck Patent GmbH

Inventors Friedlander, Martin; Lang, Ulrich; Haunschild, Jutta; Wiesner, Matthias; Bender, Hans Markus

Agent Davies Collison Cave

Pub. Number AU-B-2002319282

PCT Number PCT/EP02/07377

PCT Pub. Number WO2003/013511

Priority 60/308,851 01.08.01 US

Filing date 3 July 2002

Wipo publication date 24 February 2003

Acceptance publication date 28 June 2007

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 31/335 (2006.01) - having oxygen as the only ring hetero atom, e.g. fungichromin

A61K 31/351 (2006.01) - not condensed with another ring

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/38 (2006.01) - having sulfur as a ring hetero atom

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 31/405 (2006.01)

A61K 31/4178 (2006.01)

A61K 31/4184 (2006.01)

A61K 31/4433 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/538 (2006.01)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/12 (2006.01) Medicinal preparations containing peptides - Cyclic peptides

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61P 27/02 (2006.01) Drugs for disorders of the senses